home icon

right icon

Stocks

right icon

BAJAJHCARE

BAJAJHCARE

Pharmaceuticals & Drugs

405.85

0.00 (0.00%)

stock change
Market Cap1,061 CrEPS22.9High398.7
Stock P/E16.8Net Profit MarginNALow391.2
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
explain

Bajaj Healthcare Price chart

explain

NSE: Bajaj Healthcare

explain

Performance

Today’s Low

Today’s High

391.2

398.7

52W Low

52W High

257.45

496.3

Open Price386.9Volume201
Prev. Close386.9
explain

Fundamentals

explain
Market Cap1,061 CrROE24.3%
P/E Ratio(TTM)16.8EPS(TTM)NA
P/B Ratio3.0Dividend Yield0.4%
Industry P/E63.6Book Value129.3
Face Value5.0
explain

About the Company

The company was incorporated as Bajaj Healthcare Private Limited on July 15, 1993 under the Companies Act, 1956, with the Registrar of Companies, Mumbai bearing Registration Number - 072892. The status of the company was changed to a public limited company and the name of the company was changed to Bajaj Healthcare Limited by a special resolution passed on March 15, 2005. A fresh certificate of incorporation consequent to the change of name was granted to the company on March 31, 2005, by the Registrar of Companies, Mumbai. The company began its operations in the year 1993 with an API manufacturing unit in Tarapur, near Mumbai. Over the years it has expanded its scale and scope of operations and currently it operates five manufacturing units for manufacture of APIs, Intermediates and Formulations.

The company’s present product portfolio consists of various APIs in the therapeutic categories of Neutraceutical (Amino Acids), Vitamins, Anti-Convulsants, Bactericidal & Bacteriostatic, Diuretic & Vasodilator, Mineral & Nutritional supplements, Bronchodilater / Anti-asthmatic and Nootropics. The company’s Formulations unit manufactures tablets, capsules and sachets for its own brands as well as under Loan License (job work) for other pharmaceutical companies. Currently, the company manufactures formulations for GlaxoSmithKline Pharmaceuticals (GSK) and USV (USV) on a Loan License basis. The formulations manufactured for its own brands are manufactured and marketed under a separate division of Bajaj Medicare and it also has marketing tie-up with TTK Healthcare. The FDFs manufactured by it covers various therapeutic segments like Antibiotics, Anti-Arrhythmia, Anti-Convulsants, Anti-Diabetes, Anti-Platelets, NSAIDs, Vitamins & its Derivatives, Anti-Hypertensive, Anti-Bacterial, Anti-Malarial, Cholinesterase Inhibitors, etc.

With the combined production of its API facilities and that of its Formulation unit, the company’s product portfolio consists of APIs and FDFs which shall be marketed in domestic and international markets as branded generics. Presently it is supplying its APIs and FDFs both domestically and exporting to various countries in regions like, Europe, USA, Australia, Africa, South America, etc. With its long standing operations and quality products, the company has built a strong relationship with its customers for both APIs and FDFs. Some of its major clients include nationally and internationally known pharmaceutical companies like Glaxo Smithkline Consumer Healthcare, Ava Inc., Abbott Healthcare, Piramal Enterprises, Pfizer, Colgate Palmolive India, Lupin and Intas Pharmaceuticals to name a few.

Business area of the company

Bajaj Healthcare is a pharmaceutical company with manufacturing and marketing capabilities in Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins, Amino Acids, Anti-Convulsants and Finished Dosage Forms (FDFs) caters to various therapeutic segments.

Major events

  • 1993-1994: Incorporated under Companies Act, 1956 as Bajaj Healthcare Private Limited by setting up plant at Tarapur.
  • 1996-1997: First Export Sale.
  • 2004-2005: Changed the status of the company from Private to Public i.e. to Bajaj Healthcare Limited.
  • 2005-2006: Purchase and Set-up a new facility at Salvi, Vadodara.
  • 2005-2006: Set up Corporate Office in Masjid Bunder.
  • 2006-2007: Purchase addition Plot N- 128 at Tarapur.
  • 2006-2007: Issued 20,00,000, Non- Cumulative Preference Shares of Rs 10 each.
  • 2006-2007: Major Term loan of Rs 863.00 lakhs was sanction and its total indebtedness reached to Rs 2,265 Lakh.
  • 2007-2008 Purchase and Set-up a new facility at Manjusar, Vadodara.
  • 2007-2008 Increase in Capacity of its major products like; 100% Vitamin C and its derivatives and 50% in Choline Bitartrate, etc.
  • 2009-2010: Launched own brands under Manjusar/ Medicare.
  • 2013-2014: Purchase and Set-up a new facility at Panoli, Ankleshwar.
  • 2013-2014: First GVK Agreement.
  • 2013-2014: First USV Agreement.
  • 2014-2015: Purchase and Set-up a Second facility at Tarapur, Maharashtra.
  • 2015-2016: Acquisition of premises for new Corporate Office in Thane and set-up of the same.
Parent OrganisationBajaj Healthcare Ltd.Managing DirectorSajankumar Rameshwarlal Bajaj
Founded1993NSE SymbolBAJAJHCARE
explain

Shareholding Pattern

explain

Peer Comparison

Company52 WeekMarket PriceP/E Ratio
SEE MORE
explain

Recently Viewed

No Recently Viewed Stocks
explain

Frequently asked questions

You can buy the shares of Bajaj Healthcare using the Trinkerr Website or by downloading the Trinkerr app from Android and Apptore.